Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study
Open Access
- 16 January 2022
- journal article
- research article
- Published by Elsevier BV in EBioMedicine
- Vol. 75, 103810
- https://doi.org/10.1016/j.ebiom.2021.103810
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!)The Lancet, 2016
- The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particlesJournal of General Virology, 2016
- A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine PlatformJournal of Virology, 2015
- Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trialThe Lancet Infectious Diseases, 2015
- Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoproteinVirology, 2014
- A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virusVaccine, 2013
- Toxicology, biodistribution and shedding profile of a recombinant measles vaccine vector expressing HIV-1 antigens, in cynomolgus macaquesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 2012
- WHO position on measles vaccinesVaccine, 2009
- A Molecularly Cloned Schwarz Strain of Measles Virus Vaccine Induces Strong Immune Responses in Macaques and Transgenic MiceJournal of Virology, 2003